文献速递牙周病

亚甲基蓝光动力疗法辅助龈下再刮治在唐氏综合征患者残余牙周袋中的随机对照试验

Adjunctive methylene blue-based antimicrobial photodynamic therapy in the re-instrumentation of residual periodontal pockets in individuals with down syndrome: A randomized controlled clinical trial.
PubMed 文献 · J Dent · 2025-08-25

本研究纳入30例唐氏综合征合并I-III期B级牙周炎患者,随机分入单纯龈下刮治组(SI)与刮治联合单次亚甲基蓝光动力疗法组(SI+aPDT),比较基线、60天和90天的牙周临床指标及龈沟液IL-17等免疫指标。结果显示两组在探诊出血、探诊深度和IL-17水平上均有改善,但组间比较无统计学显著差异,提示单次aPDT辅助治疗未带来额外临床获益。

要点

  • 唐氏综合征牙周炎患者残余牙周袋再刮治时,单次亚甲基蓝aPDT未显示额外临床获益。
  • 两组在60天和90天均观察到探诊出血减少,SI组90天时4-5mm探诊深度比例显著降低。
  • 两组IL-17水平在60天和90天均显著下降,但组间比较无统计学显著差异。

核心结论

  • 在唐氏综合征合并I-III期B级牙周炎患者中,单次亚甲基蓝aPDT辅助非手术治疗残余牙周袋未产生额外临床获益。

研究设计与样本

  • 随机对照临床试验,纳入30例唐氏综合征合并I-III期B级牙周炎患者,分为SI组(n=17)和SI+aPDT组(n=17)。
  • SI+aPDT组对探诊深度≥4mm且探诊出血的残余牙周袋行单次龈下刮治,随后以100 µg/ml亚甲基蓝冲洗60秒,再用100 mW二极管激光照射50秒。
  • 评估基线、60天和90天的探诊深度、探诊出血、临床附着水平及IL-17、IL-1B、IL-6、IL-8水平,统计检验α=5%。

主要发现

  • SI+aPDT组在60天和90天探诊出血减少,SI组仅在90天探诊出血减少。
  • SI组在90天时4-5mm探诊深度百分比显著降低。
  • 两组IL-17水平在60天和90天均显著下降。
  • 组间比较各项指标均无统计学显著差异。

关键数值与推荐

  • aPDT方案:亚甲基蓝浓度100 µg/ml,冲洗后等待60秒,二极管激光功率100 mW,照射50秒。
  • 纳入残余牙周袋标准:探诊深度≥4mm且探诊出血。
  • 临床操作对应牙周治疗第三步,针对残余牙周袋。

临床怎么用

  • 对唐氏综合征牙周炎患者行残余牙周袋再刮治时,单次亚甲基蓝aPDT不宜作为常规辅助以追求额外临床获益。
  • 常规龈下刮治仍是此类患者牙周第三步治疗的基础。

局限性

  • 原文未报告样本量估算依据。
  • 原文未报告组间基线差异的统计结果。
  • 原文未报告失访情况。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: The aim of this study was to evaluate the use of a single session antimicrobial photodynamic therapy (aPDT) protocol in the re-instrumentation of residual periodontal pockets in individuals with Down Syndrome (DS). METHODS: 30 individuals with DS and stages I-III grade B periodontitis were allocated into the following groups: SI (n = 17): subgingival instrumentation (SI) in a single session; SI+aPDT (n = 17): SI in single session in residual pockets with probing depth (PD) ≥4 mm and bleeding on probing (BoP), methylene blue irrigation (100 µg/ml) after 60 s, and diode laser irradiation at 100 mW for 50 s. Periodontal clinical parameters PD, BoP, clinical attachment level (CAL) and immunological analysis interleukin (IL)-17, IL-1B, IL-6, IL-8 were evaluated at baseline and on 60 and 90 days. The clinical procedures performed in this study correspond to step 3 periodontal therapy, targeting residual periodontal pockets. All data were submitted to statistical analysis (α=5 %). RESULTS: A reduction in BoP was observed at 60 and 90 days in the SI+ aPDT group and in the SI group at 90 days. In the SI group, there was a significant reduction in the percentage of PD 4-5 mm at 90 days. Both groups showed a significant reduction in IL-17 levels on 60 and 90 days. The intergroup comparison has revealed no statistically significant differences. CONCLUSION: The use of single session aPDT protocol by methylene blue as an adjuvant to non-surgical periodontal treatment in residual periodontal pockets does not promote additional clinical benefits in individuals with DS and periodontitis. CLINICAL SIGNIFICANCE: The use of aPDT protocol with methylene blue in the re-instrumentation of residual periodontal pockets does not provide significant clinical advantages in individuals with stage I-III periodontitis and DS. These findings suggest that single-session aPDT may not enhance clinical or immunological outcomes beyond those achieved by conventional subgingival instrumentation alone during the step 3 of periodontal therapy.

来源:J Dent,查看原文。版权归原作者所有。

引用

  1. Petrilli PH, Rodrigues JVS, Santos MJP, et al. Adjunctive methylene blue-based antimicrobial photodynamic therapy in the re-instrumentation of residual periodontal pockets in individuals with down syndrome: A randomized controlled clinical trial. J Dent. 2025. PMID: 40865715. doi:10.1016/j.jdent.2025.106061

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。